DM effort seeks to improve outcomes through prevention, early detection of breast cancer.
Negotiating the tricky waters of breast cancer prevention. What do you do with a therapy that is proven to reduce the risk of breast cancer but also poses an increased risk of other serious problems? It's a tough question for both patients and providers, and that's precisely why some experts believe the issue might best be handled with a DM approach.
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D019468:Disease Management; D005260:Female; D006801:Humans; D011322:Primary Prevention / Q000191:economics / Q000379:methods*; D018570:Risk Assessment; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen